Journal article
Agreement Between House-Brackmann and Sunnybrook Facial Nerve Grading Systems in Bell's Palsy in Children: Secondary Analysis of a Randomized, Placebo-Controlled Multicenter Trial
A Williams, N Eapen, A Kochar, B Lawton, J Hort, A West, S George, R Berkowitz, KJ Lee, SR Dalziel, S Hearps, FE Babl
Journal of Child Neurology | SAGE PUBLICATIONS INC | Published : 2023
Abstract
Background: There is limited evidence on the use of facial nerve function grading scales in acute facial nerve paralysis in children. Objective: To investigate the agreement between and the usability of the House-Brackmann and Sunnybrook scales in children with idiopathic facial paralysis (Bell's palsy) and to compare their ease of administration. Methods: Data from a randomized controlled trial in children aged 6 months to <18 years with Bell's palsy was used. Children were recruited within 72 hours of symptom onset and assessed using the House-Brackmann and the Sunnybrook scales at baseline and at 1, 3, and 6 months until recovered. Agreement between the scales was assessed using the intra..
View full abstractGrants
Awarded by Children's Hospital Foundation
Funding Acknowledgements
The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The study was funded by a grant from the National Health and Medical Research Council (NHMRC, project grant GNT1078069), Canberra, Australia; the Emergency Medicine Foundation (EMSS-312R26-2016), Brisbane, Australia; and the Perth Children's Hospital Foundation (project grant #9670), Perth, Australia. The PREDICT research network was part funded by an NHMRC Center of Research Excellence grant (GNT1058560), Canberra, Australia; the Murdoch Children's Research Institute, Melbourne, Australia; and the Victorian Government's Operational Infrastructure Support program. FEB's time was part funded by a grant from the Royal Children's Hospital Foundation, Melbourne, Victoria, Australia, and an NHMRC Practitioner Fellowship. SRD's time was part funded by the Health Research Council of New Zealand (HRC13/556) and Cure Kids, Auckland, New Zealand. Aspen Australia (St Leonards NSW 2065, Australia) provided the study drug (prednisolone and taste matched placebo) as a donation free of charge. Aspen did not sponsor the study and had no influence on study design, execution, analysis, and publication.